Spiro[3H-indole-3,4'-piperidine] | 19136-10-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: Spiro[3H-indole-3,4'-piperidine]
• 英文别名: Spiro[indole-3,4'-piperidine]
• CAS: 19136-10-8
• 化学式: C₁₂H₁₄N₂
• mdl: MFCD11007809
• 分子量: 186.257
• InChiKey: HYZDJHJGTFYYCK-UHFFFAOYSA-N

物化性质

• 沸点：
  354.3±42.0 °C(Predicted)
• 密度：
  1.20±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.9
• 重原子数：
  14
• 可旋转键数：
  0
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.416
• 拓扑面积：
  24.4
• 氢给体数：
  1
• 氢受体数：
  2

文献信息

• [EN] SPIROINDOLINEPIPERIDINE DERIVATIVES<br/>[FR] DERIVES DE SPIROINDOLINEPIPERIDINE
  申请人：SYNGENTA LTD

  公开号：WO2003106457A1

  公开（公告）日：2003-12-24

  Insecticidal, acaricidal, nematicidal or molluscicidal compounds of formula (I) wherein Y is a single bond, C=O, C=S or C=(O)q where q is 0, 1 or 2; and R1, R2, R3, R4, R8, R9 and R10 are as defined in the claims or salts or N-oxides thereof, processes for preparing them and compositions containing them.

  化学式（I）中的杀虫剂、杀螨剂、杀线虫剂或杀软体动物剂，其中Y是单键，C=O，C=S或C=(O)q，其中q为0、1或2；以及R1、R2、R3、R4、R8、R9和R10如索赔中所定义的化合物，其盐或N-氧化物，制备它们的过程以及含有它们的组合物。
• N-linked heterocyclic antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
  申请人：Qiao Jennifer

  公开号：US20060293281A1

  公开（公告）日：2006-12-28

  The present invention provides novel ureas containing N-aryl or N-heteroaryl substituted heterocycles of Formula (I): or a stereoisomer, tautomer, pharmaceutically acceptable salt or solvate form thereof, wherein the variables A, B, D and W are as defined herein. These compounds are selective inhibitors of the human P2Y 1 receptor which can be used as medicaments.

  本发明提供了含有式(I)的N-芳基或N-杂芳基取代的杂环的新型脲类化合物： 或其立体异构体、互变异构体、药学上可接受的盐或溶剂化合物形式，其中变量A、B、D和W如本文所定义。这些化合物是人类P2Y1受体的选择性抑制剂，可用作药物。
• Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
  申请人：Tuerdi Huji

  公开号：US20050261244A1

  公开（公告）日：2005-11-24

  The present invention provides novel ureas containing N-aryl or N-heteroaryl substituted heterocycles and analogues thereof, which are selective inhibitors of the human P2Y 1 receptor. The invention also provides for various pharmaceutical compositions of the same and methods for treating diseases responsive to modulation of P2Y 1 receptor activity.

  本发明提供了含有N-芳基或N-杂环芳基取代的杂环化合物及其类似物的新型脲类化合物，这些化合物是人类P2Y1受体的选择性抑制剂。该发明还提供了相应的各种药物组合物以及调节P2Y1受体活性治疗对其敏感的疾病的方法。
• [EN] NOVEL SPIROINDOLINE COMPOUNDS<br/>[FR] NOUVEAUX COMPOSÉS DE SPIROINDOLINE
  申请人：INTERVET INT BV

  公开号：WO2013017678A1

  公开（公告）日：2013-02-07

  This invention relates to novel spiroindoline compounds of formula (I) that are generally useful as medicaments, more specifically as medicaments for animals. The medicament can preferably be used for the treatment of helminth infections and the treatment of parasitosis, such as caused by helminth infections. This invention also relates to uses of the compounds to make medicaments and treatments comprising the administration of the compounds to animals in need of the treatments. This invention also relates to the preparation of said compounds. Moreover this invention relates to pharmaceutical compositions and kits comprising the compounds.

  本发明涉及一种新型螺环吲哚烷化合物，通式为(I)，通常用作药物，更具体地用作动物药物。该药物可用于治疗蠕虫感染和寄生虫病的治疗，比如由蠕虫感染引起的寄生虫病。本发明还涉及利用这些化合物制备药物和治疗方案，包括将这些化合物用于需要治疗的动物。此外，本发明还涉及所述化合物的制备。此外，本发明还涉及包含这些化合物的药物组合物和工具包。
• [EN] S PIROINDOLINE COMPOUNDS FOR USE AS ANTHELMINTHI CS<br/>[FR] COMPOSÉS SPIROINDOLINES DESTINÉS À ÊTRE UTILISÉS COMME AGENTS ANTHELMINTHIQUES
  申请人：INTERVET INT BV

  公开号：WO2011095581A1

  公开（公告）日：2011-08-11

  This invention relates to spiroindoline compounds for the treatment of helminth infections and the treatment of parasitosis, such as caused by helminth infections. This invention also relates to uses of the compounds to make medicaments and treatments comprising the administration of the compounds to animals in need of the treatments. Moreover this invention relates to pharmaceutical compositions and kits comprising the compounds.

  这项发明涉及用于治疗蠕虫感染和寄生虫病的螺环吲哚类化合物。这项发明还涉及利用这些化合物制备药物和治疗方法，包括将这些化合物用于需要治疗的动物的治疗。此外，这项发明还涉及包含这些化合物的药物组合物和工具包。